285 related articles for article (PubMed ID: 25643768)
1. Cost-effectiveness of obstructive sleep apnea screening for patients with diabetes or chronic kidney disease.
Okubo R; Kondo M; Hoshi SL; Yamagata K
Sleep Breath; 2015 Sep; 19(3):1081-92. PubMed ID: 25643768
[TBL] [Abstract][Full Text] [Related]
2. Screening for obstructive sleep apnea in stroke patients: a cost-effectiveness analysis.
Brown DL; Chervin RD; Hickenbottom SL; Langa KM; Morgenstern LB
Stroke; 2005 Jun; 36(6):1291-3. PubMed ID: 15890999
[TBL] [Abstract][Full Text] [Related]
3. An integrated health-economic analysis of diagnostic and therapeutic strategies in the treatment of moderate-to-severe obstructive sleep apnea.
Pietzsch JB; Garner A; Cipriano LE; Linehan JH
Sleep; 2011 Jun; 34(6):695-709. PubMed ID: 21629357
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness Analysis of Preoperative Screening Strategies for Obstructive Sleep Apnea among Patients Undergoing Elective Inpatient Surgery.
Sankar A; Dixon PR; Sivanathan L; Memtsoudis SG; de Almeida JR; Singh M
Anesthesiology; 2020 Oct; 133(4):787-800. PubMed ID: 32930728
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness Analysis of the DiagnOSAS Screening Tool Compared With Polysomnography Diagnosis in Dutch Primary Care.
Geessinck FAJ; Pleijhuis RG; Mentink RJ; van der Palen J; Koffijberg H
J Clin Sleep Med; 2018 Jun; 14(6):1005-1015. PubMed ID: 29852908
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of chronic kidney disease mass screening test in Japan.
Kondo M; Yamagata K; Hoshi SL; Saito C; Asahi K; Moriyama T; Tsuruya K; Yoshida H; Iseki K; Watanabe T
Clin Exp Nephrol; 2012 Apr; 16(2):279-91. PubMed ID: 22167460
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Potential Cost-Effectiveness of Patient Decision Aids for Use in Adults with Obstructive Sleep Apnea: A Case Study.
Trenaman L; Sadatsafavi M; Almeida F; Ayas N; Lynd L; Marra C; Stacey D; Bansback N
Med Decis Making; 2015 Jul; 35(5):671-82. PubMed ID: 25344130
[TBL] [Abstract][Full Text] [Related]
8. A health-economic analysis of diagnosis and treatment of obstructive sleep apnea with continuous positive airway pressure in relation to cardiovascular disease. The Greek experience.
Trakada G; Economou NT; Nena E; Trakada A; Zarogoulidis P; Steiropoulos P
Sleep Breath; 2015 May; 19(2):467-72. PubMed ID: 25138389
[TBL] [Abstract][Full Text] [Related]
9. The challenge of undiagnosed sleep apnea in low-risk populations: a decision analysis.
Bianchi MT; Hershman S; Bahadoran M; Ferguson M; Westover MB
Mil Med; 2014 Aug; 179(8 Suppl):47-54. PubMed ID: 25102549
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of continuous positive airway pressure therapy for obstructive sleep apnea: health care system and societal perspectives.
Streatfeild J; Hillman D; Adams R; Mitchell S; Pezzullo L
Sleep; 2019 Dec; 42(12):. PubMed ID: 31403163
[TBL] [Abstract][Full Text] [Related]
11. Screening for proteinuria in US adults: a cost-effectiveness analysis.
Boulware LE; Jaar BG; Tarver-Carr ME; Brancati FL; Powe NR
JAMA; 2003 Dec; 290(23):3101-14. PubMed ID: 14679273
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes and cost-effectiveness of continuous positive airway pressure to manage obstructive sleep apnea in patients with type 2 diabetes in the U.K.
Guest JF; Panca M; Sladkevicius E; Taheri S; Stradling J
Diabetes Care; 2014; 37(5):1263-71. PubMed ID: 24705611
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis.
Howard K; White S; Salkeld G; McDonald S; Craig JC; Chadban S; Cass A
Value Health; 2010; 13(2):196-208. PubMed ID: 19878493
[TBL] [Abstract][Full Text] [Related]
14. COST-EFFECTIVENESS OF TREATMENTS FOR MILD-TO-MODERATE OBSTRUCTIVE SLEEP APNEA IN FRANCE.
Poullié AI; Cognet M; Gauthier A; Clementz M; Druais S; Späth HM; Perrier L; Scemama O; Pichon CR; Harousseau JL
Int J Technol Assess Health Care; 2016 Jan; 32(1-2):37-45. PubMed ID: 26956455
[TBL] [Abstract][Full Text] [Related]
15. The use of ambulatory strategies for the diagnosis and treatment of obstructive sleep apnea in adults.
Chiner E; Andreu AL; Sancho-Chust JN; Sánchez-de-la-Torre A; Barbé F
Expert Rev Respir Med; 2013 Jun; 7(3):259-73. PubMed ID: 23734648
[TBL] [Abstract][Full Text] [Related]
16. Screening for Asymptomatic Coronary Artery Disease in Waitlisted Kidney Transplant Candidates: A Cost-Utility Analysis.
Ying T; Tran A; Webster AC; Klarenbach SW; Gill J; Chadban S; Morton R
Am J Kidney Dis; 2020 May; 75(5):693-704. PubMed ID: 31810731
[TBL] [Abstract][Full Text] [Related]
17. Decision Modeling in Sleep Apnea: The Critical Roles of Pretest Probability, Cost of Untreated Obstructive Sleep Apnea, and Time Horizon.
Moro M; Westover MB; Kelly J; Bianchi MT
J Clin Sleep Med; 2016 Mar; 12(3):409-18. PubMed ID: 26518699
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness Analysis of Intracapsular Tonsillectomy and Total Tonsillectomy for Pediatric Obstructive Sleep Apnea.
Bagwell K; Wu X; Baum ED; Malhotra A
Appl Health Econ Health Policy; 2018 Aug; 16(4):527-535. PubMed ID: 29797301
[TBL] [Abstract][Full Text] [Related]
19. Screening for chronic kidney disease in Canadian indigenous peoples is cost-effective.
Ferguson TW; Tangri N; Tan Z; James MT; Lavallee BDA; Chartrand CD; McLeod LL; Dart AB; Rigatto C; Komenda PVJ
Kidney Int; 2017 Jul; 92(1):192-200. PubMed ID: 28433383
[TBL] [Abstract][Full Text] [Related]
20. Simple obstructive sleep apnea patients without hypertension or diabetes accelerate kidney dysfunction: a population follow-up cohort study from Taiwan.
Lin YS; Liu PH; Lin SW; Chuang LP; Ho WJ; Chou YT; Juan KC; Lo MT; Chu PH; Chen NH
Sleep Breath; 2017 Mar; 21(1):85-91. PubMed ID: 27380033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
